1+1 is greater than 2 !

Based on the latest clinical progress, the bispecific antibody platform of EXCYTE, which combins two unique monoclonal antibody into one, has been tested as a novel molecule to realize the activity ef

<m met-id=86 met-table=news met-field=keywords></m>

Based on the latest clinical progress, the bispecific antibody platform of EXCYTE, which combins two unique monoclonal antibody into one, has been tested as a novel molecule to realize the activity effect of 1+1>2.